Tokyo, Jan. 14 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060333) titled 'Utility of EUS attenuation imaging for diagnosis and severity of steatohepatitis: a multicenter prospective study' on Jan. 14.
Study Type:
Observational
Primary Sponsor:
Institute - Wakayama medical university
Condition:
Condition - steatohepatitis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - We evaluate the utility of EUS-AI for the diagnosis of steatohepatitis in clinical practice.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 18
years-old
=
Gender - Male and Female
Key inclusion criteria - 1. Patients over 18 years old
2. Patients scheduled for EUS and CT
Key exclusion criteria - 1. Cases in which EUS is difficult to perform
2. Patients who are judged to be ineligible for this study by the investigator
3. Patients with psychiatric disorders
Target Size - 600
Recruitment Status:
Recruitment status - Completed
Date of protocol fixation - 2024 Year 02 Month 29 Day
Date of IRB - 2024 Year 04 Month 02 Day
Anticipated trial start date - 2024 Year 10 Month 09 Day
Last follow-up date - 2025 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062315
Disclaimer: Curated by HT Syndication.
